...gains were Shattuck Labs Inc. (NASDAQ:STTK) and Spruce Biosciences Inc....
...CD172a; SHPS-1) - Signal regulatory protein alpha Paul Bonanos Spruce Biosciences Inc. Shattuck...

...million in March for its pipeline of TCR bispecifics (see “Immunocore’s $130M series B” ). Spruce Biosciences Inc....
...a principal at consulting firm Ceutec LLC, which he founded. Robin Sawka, BioCentury Staff Editas Medicine Inc. Immunocore Ltd. Spruce Biosciences Inc. Frazier...

...hyperplasia (CAH). Omega Funds and Abingworth co-led the new $88 million series B round for Spruce Biosciences Inc....
...Targets ACTH - adrenocorticotropic hormone CRFR1 (CRHR1) - Corticotropin-releasing factor receptor 1 Paul Bonanos, Associate Editor SPR001 Spruce Biosciences Inc. tildacerfont...

...prepared for every eventuality,” he said. Amran Gowani, Senior Editor, Research & Analytics SPR001 Novo Holdings A/S RiverVest Venture Partners Spruce Biosciences Inc. congenital...

...On Oct. 12, Spruce Biosciences Inc. (San Francisco, Calif.) revealed a $20 million series A round of funding...
...Novo’s Tiba Aynechi and RiverVest’s Niall O’Donnell joined Spruce's board. Spruce Biosciences Inc. , San Francisco, Calif. Meghan Sullivan SPR001 Spruce Biosciences Inc....

...Grey, and CMO Michael Huang. Novo’s Tiba Aynechi and RiverVest’s Niall O’Donnell joined Spruce's board. Paul Bonanos SPR001 Spruce Biosciences Inc....